According to Latest Research, the global market for Meropenem for Injection should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Meropenem for Injection market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Meropenem for Injection market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, 0.25g segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Hospitals has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.
The global key manufacturers of Meropenem for Injection include Sumitomo Dainippon Pharma Co.,Ltd., Joincare Pharmaceutical, Zhejiang Hisun, CSPC, Pfizer, Haikou Pharmaceutical Factory, PKU Healthcare, Shanghai Xinya Pharmaceutical and Shandong Luoxin Parmaceutical Group, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Meropenem for Injection. Report Highlights:
(1) Global Meropenem for Injection market size (sales volume & revenue), history data from 2019-2023 and forecast data from 2023 to 2030.
(2) Global Meropenem for Injection market competitive situation, sales, revenue, price and market share, from 2019 to 2023.
(3) China Meropenem for Injection market competitive situation, sales, revenue, price and market share, from 2019 to 2023.
(4) Global Meropenem for Injection segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Meropenem for Injection segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Meropenem for Injection, capacity, production and trends.
(7) Meropenem for Injection industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
0.25g
0.5g
1g
Market segment by application, can be divided into
Hospitals
Clinics
Other
Market segment by players, this report covers
Sumitomo Dainippon Pharma Co.,Ltd.
Joincare Pharmaceutical
Zhejiang Hisun
CSPC
Pfizer
Haikou Pharmaceutical Factory
PKU Healthcare
Shanghai Xinya Pharmaceutical
Shandong Luoxin Parmaceutical Group
Shenghuaxi
North China Pharmaceutical Group
Mylan
Amneal Pharmaceuticals
Auromedics Pharmaceuticals
BBraun
Fresenius Kabi
Sandoz
Bionova Scientific
Macleods Pharmaceuticals
1 Market Overview
1.1 Meropenem for Injection Definition
1.2 Global Meropenem for Injection Market Size and Forecast
1.2.1 By Revenue, Global Meropenem for Injection Market Size, 2019-2030
1.2.2 By Sales Volume, Global Meropenem for Injection Market Size, 2019-2030
1.2.3 Global Meropenem for Injection Price Trend, 2019-2030
1.3 China Meropenem for Injection Market Size and Forecast
1.3.1 By Revenue, China Meropenem for Injection Market Size, 2019-2030
1.3.2 By Sales Volume, China Meropenem for Injection Market Size, 2019-2030
1.3.3 China Meropenem for Injection Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Meropenem for Injection Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Meropenem for Injection Share in Global Market, 2019-2030
1.4.3 Meropenem for Injection Market Size: China VS Global, 2019-2030
1.5 Meropenem for Injection Market Dynamics
1.5.1 Meropenem for Injection Market Drivers
1.5.2 Meropenem for Injection Market Restraints
1.5.3 Meropenem for Injection Industry Trends
1.5.4 Meropenem for Injection Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Meropenem for Injection Revenue by Company, 2019-2023
2.2 Global Meropenem for Injection Sales Volume by Company, 2019-2023
2.3 Global Meropenem for Injection Price by Company, 2019-2023
2.4 Global Meropenem for Injection Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Meropenem for Injection Concentration Ratio
2.6 Global Meropenem for Injection Mergers & Acquisitions, Expansion Plans
2.7 Global Meropenem for Injection Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Meropenem for Injection Revenue by Company, 2019-2023
3.2 China Meropenem for Injection Sales Volume by Company, 2019-2023
3.3 China Meropenem for Injection Meropenem for Injection Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Meropenem for Injection Market, Sales Percentage of Local Players VS Foreign Players (2019-2023)
3.5 Chinese Local Players, Meropenem for Injection Domestic VS Export
3.6 China Market, Meropenem for Injection Import & Export
3.6.1 China Market, Meropenem for Injection Import & Export, 2019-2030
3.6.2 China Meropenem for Injection Import & Export Trends
3.6.3 Main Sources of China Meropenem for Injection Import
3.6.4 Export Destination of China Meropenem for Injection
4 Meropenem for Injection Production by Region
4.1 Global Meropenem for Injection Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Meropenem for Injection Manufacturers
4.3 Global Major Manufacturers, Meropenem for Injection Capacity Expansion and Future Plans
4.4 Global Meropenem for Injection Capacity by Region
4.5 Global Meropenem for Injection Production by Region
4.5.1 Global Meropenem for Injection Production & Forecast by Region, 2019 VS 2023 VS 2030
4.5.2 Global Meropenem for Injection Production by Region, 2019-2023
4.5.3 Global Meropenem for Injection Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Meropenem for Injection Industry Chain
5.2 Meropenem for Injection Upstream Analysis
5.2.1 Meropenem for Injection Core Raw Materials
5.2.2 Main Manufacturers of Meropenem for Injection Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Meropenem for Injection Production Mode
5.6 Meropenem for Injection Procurement Model
5.7 Meropenem for Injection Industry Sales Model and Sales Channels
5.7.1 Meropenem for Injection Sales Model
5.7.2 Meropenem for Injection Typical Distributors
6 Sights by Type
6.1 Meropenem for Injection Classification
6.1.1 0.25g
6.1.2 0.5g
6.1.3 1g
6.2 By Type, Global Meropenem for Injection Market Size & CAGR, 2019 VS 2023 VS 2030
6.3 By Type, Global Meropenem for Injection Revenue, 2019-2030
6.4 By Type, Global Meropenem for Injection Sales Volume, 2019-2030
6.5 By Type, Global Meropenem for Injection Price, 2019-2030
7 Sights by Application
7.1 Meropenem for Injection Segment by Application
7.1.1 Hospitals
7.1.2 Clinics
7.1.3 Other
7.2 By Application, Global Meropenem for Injection Market Size & CAGR, 2019 VS 2023 VS 2030
7.3 By Application, Global Meropenem for Injection Revenue, 2019-2030
7.4 By Application, Global Meropenem for Injection Sales Volume, 2019-2030
7.5 By Application, Global Meropenem for Injection Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Meropenem for Injection Market Size, 2019 VS 2023 VS 2030
8.2 By Region, Global Meropenem for Injection Revenue, 2019-2030
8.3 By Region, Global Meropenem for Injection Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Meropenem for Injection Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Meropenem for Injection Market Size Market Share
8.5 Europe
8.5.1 Europe Meropenem for Injection Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Meropenem for Injection Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Meropenem for Injection Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Meropenem for Injection Market Size Market Share
8.7 South America
8.7.1 South America Meropenem for Injection Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Meropenem for Injection Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Meropenem for Injection Market Size & CAGR,2019 VS 2023 VS 2030
9.2 By Country, Global Meropenem for Injection Revenue, 2019-2030
9.3 By Country, Global Meropenem for Injection Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Meropenem for Injection Market Size, 2019-2030
9.4.2 By Company, U.S. Meropenem for Injection Sales Volume Market Share, 2023
9.4.3 By Type, U.S. Meropenem for Injection Market Size, Share, 2023 VS 2030
9.4.4 By Application, U.S. Meropenem for Injection Market Size, Share, 2023 VS 2030
9.5 Europe
9.5.1 Europe Meropenem for Injection Market Size, 2019-2030
9.5.2 By Company, Europe Meropenem for Injection Sales Volume Market Share, 2023
9.5.3 By Type, Europe Meropenem for Injection Market Size, Share, 2023 VS 2030
9.5.4 By Application, Europe Meropenem for Injection Market Size, Share, 2023 VS 2030
9.6 China
9.6.1 China Meropenem for Injection Market Size, 2019-2030
9.6.2 By Company, China Meropenem for Injection Sales Volume Market Share, 2023
9.6.3 By Type, China Meropenem for Injection Market Size, Share, 2023 VS 2030
9.6.4 By Application, China Meropenem for Injection Market Size, Share, 2023 VS 2030
9.7 Japan
9.7.1 Japan Meropenem for Injection Market Size, 2019-2030
9.7.2 By Company, Japan Meropenem for Injection Sales Volume Market Share, 2023
9.7.3 By Type, Japan Meropenem for Injection Market Size, Share, 2023 VS 2030
9.7.4 By Application, Japan Meropenem for Injection Market Size, Share, 2023 VS 2030
9.8 South Korea
9.8.1 South Korea Meropenem for Injection Market Size, 2019-2030
9.8.2 By Company, South Korea Meropenem for Injection Sales Volume Market Share, 2023
9.8.3 By Type, South Korea Meropenem for Injection Market Size, Share, 2023 VS 2030
9.8.4 By Application, South Korea Meropenem for Injection Market Size, Share, 2023 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Meropenem for Injection Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Meropenem for Injection Sales Volume Market Share, 2023
9.9.3 By Type, Southeast Asia Meropenem for Injection Market Size, Share, 2023 VS 2030
9.9.4 By Application, Southeast Asia Meropenem for Injection Market Size, Share, 2023 VS 2030
9.10 India
9.10.1 India Meropenem for Injection Market Size, 2019-2030
9.10.2 By Company, India Meropenem for Injection Sales Volume Market Share, 2023
9.10.3 By Type, India Meropenem for Injection Market Size, Share, 2023 VS 2030
9.10.4 By Application, India Meropenem for Injection Market Size, Share, 2023 VS 2030
9.11 Middle East & Asia
9.11.1 Middle East & Asia Meropenem for Injection Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Meropenem for Injection Sales Volume Market Share, 2023
9.11.3 By Type, Middle East & Asia Meropenem for Injection Market Size, Share, 2023 VS 2030
9.11.4 By Application, Middle East & Asia Meropenem for Injection Market Size, Share, 2023 VS 2030
10 Manufacturers Profile
10.1 Sumitomo Dainippon Pharma Co.,Ltd.
10.1.1 Sumitomo Dainippon Pharma Co.,Ltd. Company Information, Head Office, Market Area and Industry Position
10.1.2 Sumitomo Dainippon Pharma Co.,Ltd. Meropenem for Injection Models, Specifications and Application
10.1.3 Sumitomo Dainippon Pharma Co.,Ltd. Meropenem for Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.1.4 Sumitomo Dainippon Pharma Co.,Ltd. Company Profile and Main Business
10.1.5 Sumitomo Dainippon Pharma Co.,Ltd. Recent Developments
10.2 Joincare Pharmaceutical
10.2.1 Joincare Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.2.2 Joincare Pharmaceutical Meropenem for Injection Models, Specifications and Application
10.2.3 Joincare Pharmaceutical Meropenem for Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.2.4 Joincare Pharmaceutical Company Profile and Main Business
10.2.5 Joincare Pharmaceutical Recent Developments
10.3 Zhejiang Hisun
10.3.1 Zhejiang Hisun Company Information, Head Office, Market Area and Industry Position
10.3.2 Zhejiang Hisun Meropenem for Injection Models, Specifications and Application
10.3.3 Zhejiang Hisun Meropenem for Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.3.4 Zhejiang Hisun Company Profile and Main Business
10.3.5 Zhejiang Hisun Recent Developments
10.4 CSPC
10.4.1 CSPC Company Information, Head Office, Market Area and Industry Position
10.4.2 CSPC Meropenem for Injection Models, Specifications and Application
10.4.3 CSPC Meropenem for Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.4.4 CSPC Company Profile and Main Business
10.4.5 CSPC Recent Developments
10.5 Pfizer
10.5.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.5.2 Pfizer Meropenem for Injection Models, Specifications and Application
10.5.3 Pfizer Meropenem for Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.5.4 Pfizer Company Profile and Main Business
10.5.5 Pfizer Recent Developments
10.6 Haikou Pharmaceutical Factory
10.6.1 Haikou Pharmaceutical Factory Company Information, Head Office, Market Area and Industry Position
10.6.2 Haikou Pharmaceutical Factory Meropenem for Injection Models, Specifications and Application
10.6.3 Haikou Pharmaceutical Factory Meropenem for Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.6.4 Haikou Pharmaceutical Factory Company Profile and Main Business
10.6.5 Haikou Pharmaceutical Factory Recent Developments
10.7 PKU Healthcare
10.7.1 PKU Healthcare Company Information, Head Office, Market Area and Industry Position
10.7.2 PKU Healthcare Meropenem for Injection Models, Specifications and Application
10.7.3 PKU Healthcare Meropenem for Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.7.4 PKU Healthcare Company Profile and Main Business
10.7.5 PKU Healthcare Recent Developments
10.8 Shanghai Xinya Pharmaceutical
10.8.1 Shanghai Xinya Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.8.2 Shanghai Xinya Pharmaceutical Meropenem for Injection Models, Specifications and Application
10.8.3 Shanghai Xinya Pharmaceutical Meropenem for Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.8.4 Shanghai Xinya Pharmaceutical Company Profile and Main Business
10.8.5 Shanghai Xinya Pharmaceutical Recent Developments
10.9 Shandong Luoxin Parmaceutical Group
10.9.1 Shandong Luoxin Parmaceutical Group Company Information, Head Office, Market Area and Industry Position
10.9.2 Shandong Luoxin Parmaceutical Group Meropenem for Injection Models, Specifications and Application
10.9.3 Shandong Luoxin Parmaceutical Group Meropenem for Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.9.4 Shandong Luoxin Parmaceutical Group Company Profile and Main Business
10.9.5 Shandong Luoxin Parmaceutical Group Recent Developments
10.10 Shenghuaxi
10.10.1 Shenghuaxi Company Information, Head Office, Market Area and Industry Position
10.10.2 Shenghuaxi Meropenem for Injection Models, Specifications and Application
10.10.3 Shenghuaxi Meropenem for Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.10.4 Shenghuaxi Company Profile and Main Business
10.10.5 Shenghuaxi Recent Developments
10.11 North China Pharmaceutical Group
10.11.1 North China Pharmaceutical Group Company Information, Head Office, Market Area and Industry Position
10.11.2 North China Pharmaceutical Group Meropenem for Injection Models, Specifications and Application
10.11.3 North China Pharmaceutical Group Meropenem for Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.11.4 North China Pharmaceutical Group Company Profile and Main Business
10.11.5 North China Pharmaceutical Group Recent Developments
10.12 Mylan
10.12.1 Mylan Company Information, Head Office, Market Area and Industry Position
10.12.2 Mylan Meropenem for Injection Models, Specifications and Application
10.12.3 Mylan Meropenem for Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.12.4 Mylan Company Profile and Main Business
10.12.5 Mylan Recent Developments
10.13 Amneal Pharmaceuticals
10.13.1 Amneal Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.13.2 Amneal Pharmaceuticals Meropenem for Injection Models, Specifications and Application
10.13.3 Amneal Pharmaceuticals Meropenem for Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.13.4 Amneal Pharmaceuticals Company Profile and Main Business
10.13.5 Amneal Pharmaceuticals Recent Developments
10.14 Auromedics Pharmaceuticals
10.14.1 Auromedics Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.14.2 Auromedics Pharmaceuticals Meropenem for Injection Models, Specifications and Application
10.14.3 Auromedics Pharmaceuticals Meropenem for Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.14.4 Auromedics Pharmaceuticals Company Profile and Main Business
10.14.5 Auromedics Pharmaceuticals Recent Developments
10.15 BBraun
10.15.1 BBraun Company Information, Head Office, Market Area and Industry Position
10.15.2 BBraun Meropenem for Injection Models, Specifications and Application
10.15.3 BBraun Meropenem for Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.15.4 BBraun Company Profile and Main Business
10.15.5 BBraun Recent Developments
10.16 Fresenius Kabi
10.16.1 Fresenius Kabi Company Information, Head Office, Market Area and Industry Position
10.16.2 Fresenius Kabi Meropenem for Injection Models, Specifications and Application
10.16.3 Fresenius Kabi Meropenem for Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.16.4 Fresenius Kabi Company Profile and Main Business
10.16.5 Fresenius Kabi Recent Developments
10.17 Sandoz
10.17.1 Sandoz Company Information, Head Office, Market Area and Industry Position
10.17.2 Sandoz Meropenem for Injection Models, Specifications and Application
10.17.3 Sandoz Meropenem for Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.17.4 Sandoz Company Profile and Main Business
10.17.5 Sandoz Recent Developments
10.18 Bionova Scientific
10.18.1 Bionova Scientific Company Information, Head Office, Market Area and Industry Position
10.18.2 Bionova Scientific Meropenem for Injection Models, Specifications and Application
10.18.3 Bionova Scientific Meropenem for Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.18.4 Bionova Scientific Company Profile and Main Business
10.18.5 Bionova Scientific Recent Developments
10.19 Macleods Pharmaceuticals
10.19.1 Macleods Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.19.2 Macleods Pharmaceuticals Meropenem for Injection Models, Specifications and Application
10.19.3 Macleods Pharmaceuticals Meropenem for Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.19.4 Macleods Pharmaceuticals Company Profile and Main Business
10.19.5 Macleods Pharmaceuticals Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Meropenem for Injection Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Meropenem for Injection Market Restraints
Table 3. Meropenem for Injection Market Trends
Table 4. Meropenem for Injection Industry Policy
Table 5. Global Meropenem for Injection Revenue by Company, 2019-2023, US$ million
Table 6. Global Meropenem for Injection Revenue Market Share by Company, 2019-2023
Table 7. Global Meropenem for Injection Sales Volume by Company, 2019-2023, (K Units)
Table 8. Global Meropenem for Injection Sales Volume Market Share by Company, 2019-2023
Table 9. Global Meropenem for Injection Price by Company, 2019-2023, (US$/Unit)
Table 10. Global Meropenem for Injection Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Meropenem for Injection Mergers & Acquisitions, Expansion Plans
Table 12. Global Meropenem for Injection Manufacturers Product Type
Table 13. China Meropenem for Injection Revenue by Company, 2019-2023, US$ million
Table 14. China Meropenem for Injection Revenue Market Share by Company, 2019-2023
Table 15. China Meropenem for Injection Sales Volume by Company, 2019-2023, (K Units)
Table 16. China Meropenem for Injection Sales Volume Market Share by Company, 2019-2023
Table 17. China Market, Meropenem for Injection Production, Sales, Import and Export, 2019-2030, (K Units)
Table 18. China Meropenem for Injection Import & Export Trends
Table 19. Main Sources of China Meropenem for Injection Import
Table 20. Export Destination of China Meropenem for Injection
Table 21. Global Headquarters and Manufacturing Base of Meropenem for Injection Manufacturers
Table 22. Global Major Manufacturers, Meropenem for Injection Capacity Expansion and Future Plans
Table 23. Global Meropenem for Injection Production & Forecast by Region, 2019 VS 2023 VS 2030, (K Units)
Table 24. Global Meropenem for Injection Production by Region, 2019-2023, (K Units)
Table 25. Global Meropenem for Injection Production Forecast by Region, 2024-2030, (K Units)
Table 26. Global Key Players of Meropenem for Injection Upstream (Raw Materials)
Table 27. Global Meropenem for Injection Typical Customers
Table 28. Meropenem for Injection Typical Distributors
Table 29. By Type, Global Meropenem for Injection Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million
Table 30. By Application, Global Meropenem for Injection Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million
Table 31. By Region, Global Meropenem for Injection Market Size, 2019 VS 2023 VS 2030, US$ Million
Table 32. By Region, Global Meropenem for Injection Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Meropenem for Injection Sales Volume, 2019-2030, (K Units)
Table 34. By Country, Global Meropenem for Injection Revenue & CAGR,2019 VS 2023 VS 2030, US$ Million
Table 35. By Country, Global Meropenem for Injection Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Meropenem for Injection Revenue Market Share, 2019-2030
Table 37. By Country, Global Meropenem for Injection Sales Volume, 2019-2030, (K Units)
Table 38. By Country, Global Meropenem for Injection Sales Volume Market Share, 2019-2030
Table 39. Sumitomo Dainippon Pharma Co.,Ltd. Company Information, Head Office, Market Area and Industry Position
Table 40. Sumitomo Dainippon Pharma Co.,Ltd. Meropenem for Injection Models, Specifications and Application
Table 41. Sumitomo Dainippon Pharma Co.,Ltd. Meropenem for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 42. Sumitomo Dainippon Pharma Co.,Ltd. Company Profile and Main Business
Table 43. Sumitomo Dainippon Pharma Co.,Ltd. Recent Developments
Table 44. Joincare Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 45. Joincare Pharmaceutical Meropenem for Injection Models, Specifications and Application
Table 46. Joincare Pharmaceutical Meropenem for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 47. Joincare Pharmaceutical Company Profile and Main Business
Table 48. Joincare Pharmaceutical Recent Developments
Table 49. Zhejiang Hisun Company Information, Head Office, Market Area and Industry Position
Table 50. Zhejiang Hisun Meropenem for Injection Models, Specifications and Application
Table 51. Zhejiang Hisun Meropenem for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 52. Zhejiang Hisun Company Profile and Main Business
Table 53. Zhejiang Hisun Recent Developments
Table 54. CSPC Company Information, Head Office, Market Area and Industry Position
Table 55. CSPC Meropenem for Injection Models, Specifications and Application
Table 56. CSPC Meropenem for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 57. CSPC Company Profile and Main Business
Table 58. CSPC Recent Developments
Table 59. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 60. Pfizer Meropenem for Injection Models, Specifications and Application
Table 61. Pfizer Meropenem for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 62. Pfizer Company Profile and Main Business
Table 63. Pfizer Recent Developments
Table 64. Haikou Pharmaceutical Factory Company Information, Head Office, Market Area and Industry Position
Table 65. Haikou Pharmaceutical Factory Meropenem for Injection Models, Specifications and Application
Table 66. Haikou Pharmaceutical Factory Meropenem for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 67. Haikou Pharmaceutical Factory Company Profile and Main Business
Table 68. Haikou Pharmaceutical Factory Recent Developments
Table 69. PKU Healthcare Company Information, Head Office, Market Area and Industry Position
Table 70. PKU Healthcare Meropenem for Injection Models, Specifications and Application
Table 71. PKU Healthcare Meropenem for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 72. PKU Healthcare Company Profile and Main Business
Table 73. PKU Healthcare Recent Developments
Table 74. Shanghai Xinya Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 75. Shanghai Xinya Pharmaceutical Meropenem for Injection Models, Specifications and Application
Table 76. Shanghai Xinya Pharmaceutical Meropenem for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 77. Shanghai Xinya Pharmaceutical Company Profile and Main Business
Table 78. Shanghai Xinya Pharmaceutical Recent Developments
Table 79. Shandong Luoxin Parmaceutical Group Company Information, Head Office, Market Area and Industry Position
Table 80. Shandong Luoxin Parmaceutical Group Meropenem for Injection Models, Specifications and Application
Table 81. Shandong Luoxin Parmaceutical Group Meropenem for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 82. Shandong Luoxin Parmaceutical Group Company Profile and Main Business
Table 83. Shandong Luoxin Parmaceutical Group Recent Developments
Table 84. Shenghuaxi Company Information, Head Office, Market Area and Industry Position
Table 85. Shenghuaxi Meropenem for Injection Models, Specifications and Application
Table 86. Shenghuaxi Meropenem for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 87. Shenghuaxi Company Profile and Main Business
Table 88. Shenghuaxi Recent Developments
Table 89. North China Pharmaceutical Group Company Information, Head Office, Market Area and Industry Position
Table 90. North China Pharmaceutical Group Meropenem for Injection Models, Specifications and Application
Table 91. North China Pharmaceutical Group Meropenem for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 92. North China Pharmaceutical Group Company Profile and Main Business
Table 93. North China Pharmaceutical Group Recent Developments
Table 94. Mylan Company Information, Head Office, Market Area and Industry Position
Table 95. Mylan Meropenem for Injection Models, Specifications and Application
Table 96. Mylan Meropenem for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 97. Mylan Company Profile and Main Business
Table 98. Mylan Recent Developments
Table 99. Amneal Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 100. Amneal Pharmaceuticals Meropenem for Injection Models, Specifications and Application
Table 101. Amneal Pharmaceuticals Meropenem for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 102. Amneal Pharmaceuticals Company Profile and Main Business
Table 103. Amneal Pharmaceuticals Recent Developments
Table 104. Auromedics Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 105. Auromedics Pharmaceuticals Meropenem for Injection Models, Specifications and Application
Table 106. Auromedics Pharmaceuticals Meropenem for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 107. Auromedics Pharmaceuticals Company Profile and Main Business
Table 108. Auromedics Pharmaceuticals Recent Developments
Table 109. BBraun Company Information, Head Office, Market Area and Industry Position
Table 110. BBraun Meropenem for Injection Models, Specifications and Application
Table 111. BBraun Meropenem for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 112. BBraun Company Profile and Main Business
Table 113. BBraun Recent Developments
Table 114. Fresenius Kabi Company Information, Head Office, Market Area and Industry Position
Table 115. Fresenius Kabi Meropenem for Injection Models, Specifications and Application
Table 116. Fresenius Kabi Meropenem for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 117. Fresenius Kabi Company Profile and Main Business
Table 118. Fresenius Kabi Recent Developments
Table 119. Sandoz Company Information, Head Office, Market Area and Industry Position
Table 120. Sandoz Meropenem for Injection Models, Specifications and Application
Table 121. Sandoz Meropenem for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 122. Sandoz Company Profile and Main Business
Table 123. Sandoz Recent Developments
Table 124. Bionova Scientific Company Information, Head Office, Market Area and Industry Position
Table 125. Bionova Scientific Meropenem for Injection Models, Specifications and Application
Table 126. Bionova Scientific Meropenem for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 127. Bionova Scientific Company Profile and Main Business
Table 128. Bionova Scientific Recent Developments
Table 129. Macleods Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 130. Macleods Pharmaceuticals Meropenem for Injection Models, Specifications and Application
Table 131. Macleods Pharmaceuticals Meropenem for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 132. Macleods Pharmaceuticals Company Profile and Main Business
Table 133. Macleods Pharmaceuticals Recent Developments
List of Figure
Figure 1. Meropenem for Injection Picture
Figure 2. By Revenue, Global Meropenem for Injection Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Meropenem for Injection Market Size and Forecast, 2019-2030, (K Units)
Figure 4. Global Meropenem for Injection Price Trend, 2019-2030, (US$/Unit)
Figure 5. By Revenue, China Meropenem for Injection Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Meropenem for Injection Market Size and Forecast, 2019-2030, (K Units)
Figure 7. China Meropenem for Injection Price Trend, 2019-2030 (US$/Unit)
Figure 8. By Revenue, China Meropenem for Injection Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Meropenem for Injection Share of Global Market, 2019-2030
Figure 10. Global Meropenem for Injection Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 11. Global Meropenem for Injection Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2023
Figure 12. China Meropenem for Injection Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 13. China Meropenem for Injection Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 14. China Meropenem for Injection Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2023
Figure 15. Chinese Local Players, Proportion of Meropenem for Injection Domestic VS Export, 2023
Figure 16. Global Meropenem for Injection Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Meropenem for Injection Capacity Market Share by Region, 2023 VS 2030
Figure 18. Global Meropenem for Injection Production Market Share & Forecast by Region, 2019-2030
Figure 19. Meropenem for Injection Industry Chain
Figure 20. Meropenem for Injection Procurement Model
Figure 21. Meropenem for Injection Sales Model
Figure 22. Meropenem for Injection Sales Channels, Direct Sales and Distribution
Figure 23. 0.25g
Figure 24. 0.5g
Figure 25. 1g
Figure 26. By Type, Global Meropenem for Injection Revenue, 2019-2030, US$ Million
Figure 27. By Type, Global Meropenem for Injection Revenue Market Share, 2019-2030
Figure 28. By Type, Global Meropenem for Injection Sales Volume, 2019-2030, (K Units)
Figure 29. By Type, Global Meropenem for Injection Sales Volume Market Share, 2019-2030
Figure 30. By Type, Global Meropenem for Injection Price, 2019-2030, (US$/Unit)
Figure 31. Hospitals
Figure 32. Clinics
Figure 33. Other
Figure 34. By Application, Global Meropenem for Injection Revenue, 2019-2030, US$ Million
Figure 35. By Application, Global Meropenem for Injection Revenue Market Share, 2019-2030
Figure 36. By Application, Global Meropenem for Injection Sales Volume, 2019-2030, (K Units)
Figure 37. By Application, Global Meropenem for Injection Sales Volume Market Share, 2019-2030
Figure 38. By Application, Global Meropenem for Injection Price, 2019-2030, (US$/Unit)
Figure 39. By Region, Global Meropenem for Injection Revenue Market Share, 2019-2030
Figure 40. By Region, Global Meropenem for Injection Sales Volume Market Share, 2019-2030
Figure 41. North America Meropenem for Injection Revenue & Forecasts, 2019-2030, US$ Million
Figure 42. By Country, North America Meropenem for Injection Revenue Market Share, 2023
Figure 43. Europe Meropenem for Injection Revenue & Forecasts, 2019-2030, US$ Million
Figure 44. By Country, Europe Meropenem for Injection Revenue Market Share, 2023
Figure 45. Asia Pacific Meropenem for Injection Revenue & Forecasts, 2019-2030, US$ Million
Figure 46. By Country/Region, Asia Pacific Meropenem for Injection Revenue Market Share, 2023
Figure 47. South America Meropenem for Injection Revenue & Forecasts, 2019-2030, US$ Million
Figure 48. By Country, South America Meropenem for Injection Revenue Market Share, 2023
Figure 49. Middle East & Africa Meropenem for Injection Revenue & Forecasts, 2019-2030, US$ Million
Figure 50. U.S. Meropenem for Injection Sales Volume, 2019-2030, (K Units)
Figure 51. By Company, U.S. Meropenem for Injection Market Share, 2023
Figure 52. By Type, U.S. Meropenem for Injection Sales Volume Market Share, 2023 VS 2030
Figure 53. By Application, U.S. Meropenem for Injection Sales Volume Market Share, 2023 VS 2030
Figure 54. Europe Meropenem for Injection Sales Volume, 2019-2030, (K Units)
Figure 55. By Company, Europe Meropenem for Injection Market Share, 2023
Figure 56. By Type, Europe Meropenem for Injection Sales Volume Market Share, 2023 VS 2030
Figure 57. By Application, Europe Meropenem for Injection Sales Volume Market Share, 2023 VS 2030
Figure 58. China Meropenem for Injection Sales Volume, 2019-2030, (K Units)
Figure 59. By Company, China Meropenem for Injection Market Share, 2023
Figure 60. By Type, China Meropenem for Injection Sales Volume Market Share, 2023 VS 2030
Figure 61. By Application, China Meropenem for Injection Sales Volume Market Share, 2023 VS 2030
Figure 62. Japan Meropenem for Injection Sales Volume, 2019-2030, (K Units)
Figure 63. By Company, Japan Meropenem for Injection Market Share, 2023
Figure 64. By Type, Japan Meropenem for Injection Sales Volume Market Share, 2023 VS 2030
Figure 65. By Application, Japan Meropenem for Injection Sales Volume Market Share, 2023 VS 2030
Figure 66. South Korea Meropenem for Injection Sales Volume, 2019-2030, (K Units)
Figure 67. By Company, South Korea Meropenem for Injection Market Share, 2023
Figure 68. By Type, South Korea Meropenem for Injection Sales Volume Market Share, 2023 VS 2030
Figure 69. By Application, South Korea Meropenem for Injection Sales Volume Market Share, 2023 VS 2030
Figure 70. Southeast Asia Meropenem for Injection Sales Volume, 2019-2030, (K Units)
Figure 71. By Company, Southeast Asia Meropenem for Injection Market Share, 2023
Figure 72. By Type, Southeast Asia Meropenem for Injection Sales Volume Market Share, 2023 VS 2030
Figure 73. By Application, Southeast Asia Meropenem for Injection Sales Volume Market Share, 2023 VS 2030
Figure 74. India Meropenem for Injection Sales Volume, 2019-2030, (K Units)
Figure 75. By Company, India Meropenem for Injection Market Share, 2023
Figure 76. By Type, India Meropenem for Injection Sales Volume Market Share, 2023 VS 2030
Figure 77. By Application, India Meropenem for Injection Sales Volume Market Share, 2023 VS 2030
Figure 78. Middle East & Asia Meropenem for Injection Sales Volume, 2019-2030, (K Units)
Figure 79. By Company, Middle East & Asia Meropenem for Injection Market Share, 2023
Figure 80. By Type, Middle East & Asia Meropenem for Injection Sales Volume Market Share, 2023 VS 2030
Figure 81. By Application, Middle East & Asia Meropenem for Injection Sales Volume Market Share, 2023 VS 2030
Figure 82. Research Methodology
Figure 83. Breakdown of Primary Interviews
Figure 84. Bottom-up Approaches
Figure 85. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|